Feeling energized by science over the last three days #ENDO2024@TheEndoSociety key highlights were updates in molecular mechanisms of hormone-dependent cancers, new tech to study TME in endocrine cancers, and models for PPGL!
Looking forward to ENDO 2025!!
So thankful for the opportunity to present our work and learn from so many amazing researchers and colleagues throughout my fellowship @NCIResearchCtr @samira_sadowski @JimMadigan3 @StevenDForsythe see you at ENDO 2025 @TheEndoSociety
New from Surgeon-Scientist Dr. Samira Sadowski's lab:
Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model https://t.co/7nxSDgQ9Iu